$8.320
-0.345 (-4.15%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RNA por análisis de gráficos similares
Alphio's RNA stock price prediction model matches the current Atrium Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.37 (+0.58%). The 1-week path is $8.29 (-0.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Atrium Therapeutics Inc?
Avidity Biosciences Inc (RNA) is a good buy right now due to its current price of $8.55, which is significantly below its 52-week high of $73.06, indicating substantial upside potential. The RSI of 70.53 suggests that the stock is currently overbought, but the recent 5-day change of +6.21% and a strong upcoming clinical trial could drive further interest. However, the main risk is the significant insider selling, which has increased by 200.63% over the last month, indicating potential concerns about future performance.
RNA cerró en $8.32 el Thursday, tras bajar -4.15%
Atrium Therapeutics Inc (RNA) last closed at $8.3199997, losing -4.15%. These facts feed the 1-day and 1-week RNA price prediction above.
Factores de la previsión
Los factores de la previsión de Atrium Therapeutics Inc (RNA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RNA, ordenadas por similitud.
Análisis de estacionalidad de RNA
Historically the probability of a positive November return for RNA is 90.70%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.